These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. American Society of Tropical Medicine and Hygiene--55th Annual Meeting. Vaccine development against flaviviruses. 12-16 November 2006, Atlanta, GA, USA. Klade C IDrugs; 2007 Feb; 10(2):96-8. PubMed ID: 17285458 [No Abstract] [Full Text] [Related]
6. Flavivirus encephalitis. Handy R; Lang S N Engl J Med; 2004 Oct; 351(17):1803-4; author reply 1803-4. PubMed ID: 15496637 [No Abstract] [Full Text] [Related]
7. [Immunity to flavivirus in Amerindian population of the Sierra de Perijá, Zulia state, Venezuela]. Valero N; Espina LM; Estévez J; Meleán E; Larreal Y; Maldonado M; Arias J; Añez G; Añez F; Pirela J Invest Clin; 2004 Dec; 45(4):337-45. PubMed ID: 15602900 [TBL] [Abstract][Full Text] [Related]
8. Development of novel antivirals against flaviviruses. Patkar CG; Kuhn RJ Novartis Found Symp; 2006; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153 [TBL] [Abstract][Full Text] [Related]
9. Safety concerns with regard to live attenuated flavivirus vaccines. Seligman SJ; Gould EA J Infect Dis; 2008 Sep; 198(5):794-5. PubMed ID: 18694340 [No Abstract] [Full Text] [Related]
10. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys. Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826 [TBL] [Abstract][Full Text] [Related]
11. Developing vaccines against flavivirus diseases: past success, present hopes and future challenges. Stephenson JR Novartis Found Symp; 2006; 277():193-201; discussion 201-5, 251-3. PubMed ID: 17319163 [TBL] [Abstract][Full Text] [Related]
12. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Brandler S; Tangy F Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338 [TBL] [Abstract][Full Text] [Related]
13. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Kofler RM; Aberle JH; Aberle SW; Allison SL; Heinz FX; Mandl CW Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1951-6. PubMed ID: 14769933 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence of Flavivirus antibodies in Alouatta caraya primate autochthonous of Argentina]. Contigiani MS; Fernández C; Spinsanti LI; Díaz GE Medicina (B Aires); 2000; 60(3):348-50. PubMed ID: 11050814 [TBL] [Abstract][Full Text] [Related]
16. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic. Gajanana A; Thenmozhi V; Samuel PP; Reuben R Bull World Health Organ; 1995; 73(2):237-44. PubMed ID: 7743596 [TBL] [Abstract][Full Text] [Related]
18. Flavivirus Immunity in Disease Control and Viral Pathogenesis. Wang T Viral Immunol; 2020; 33(1):1-2. PubMed ID: 31905329 [No Abstract] [Full Text] [Related]
20. Flavivirus DNA vaccines: current status and potential. Chang GJ; Davis BS; Hunt AR; Holmes DA; Kuno G Ann N Y Acad Sci; 2001 Dec; 951():272-85. PubMed ID: 11797784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]